Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive BiomarkersVivian Wai Yan Lui, Jennifer R. Grandis, Kelsey Pendleton et al.|Cancer Discovery|2013Cited by 590
First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer TherapyMalabika Sen, Jennifer R. Grandis, Sufi M. Thomas et al.|Cancer Discovery|2012Cited by 313